These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Detection of antibodies to human T-lymphotropic virus type 1 (HTLV-1). Fang CT; Williams AE; Sandler SG; Slamon DJ; Poiesz BJ Transfusion; 1988; 28(2):179-83. PubMed ID: 2832983 [TBL] [Abstract][Full Text] [Related]
24. A comparison of four enzyme immunoassays for the simultaneous detection of HIV-1- and HIV-2-specific antibody. Berry NJ; Salker R; Contreras M; Barbara JA; Tedder RS J Virol Methods; 1991 Sep; 34(1):91-100. PubMed ID: 1955493 [TBL] [Abstract][Full Text] [Related]
25. Lack of screening test sensitivity during HIV-1 non-subtype B seroconversions. Apetrei C; Loussert-Ajaka I; Descamps D; Damond F; Saragosti S; Brun-Vézinet F; Simon F AIDS; 1996 Dec; 10(14):F57-60. PubMed ID: 8970678 [TBL] [Abstract][Full Text] [Related]
26. Adult and paediatric AIDS patients lacking HIV antibodies detected by enzyme immunoassay in central Africa: further serological studies. Van de Perre P; Lepage P; Batungwanayo J; Bonnet D AIDS; 1989 Jul; 3(7):429-31. PubMed ID: 2504245 [TBL] [Abstract][Full Text] [Related]
27. A simple method for improved assay demonstrates that HIV p24 antigen is present as immune complexes in most sera from HIV-infected individuals. Nishanian P; Huskins KR; Stehn S; Detels R; Fahey JL J Infect Dis; 1990 Jul; 162(1):21-8. PubMed ID: 2113075 [TBL] [Abstract][Full Text] [Related]
28. Evaluation of the concomitant use of two different EIA tests for HIV screening in blood banks. Otani MM; Salles NA; Barreto AM; Barreto CC; Chamone DF; Sabino EC Rev Panam Salud Publica; 2003; 13(2-3):172-5. PubMed ID: 12744793 [TBL] [Abstract][Full Text] [Related]
29. Evidence of serological cross-reactivities with human immunodeficiency virus types 1 and 2 and human T-lymphotropic virus types I and II in sera of pregnant women in Ibadan, Nigeria. Olaleye DO; Ekweozor CC; Sheng Z; Rasheed S Int J Epidemiol; 1995 Feb; 24(1):198-203. PubMed ID: 7797344 [TBL] [Abstract][Full Text] [Related]
30. Comparison of four different antigen-capture assays for the detection of human immunodeficiency virus antigen (HIV-Ag). Genesca J; Shih JW; Esteban JI; Alter HJ J Acquir Immune Defic Syndr (1988); 1989; 2(2):170-77. PubMed ID: 2649654 [TBL] [Abstract][Full Text] [Related]
31. An ELISA-inhibition assay for antibody to human immunodeficiency virus core antigen (p24). Povolotsky J; Gold JW; Darminin P; Chein N; Baron P; Armstrong D J Virol Methods; 1990 Oct; 30(1):109-14. PubMed ID: 2128300 [TBL] [Abstract][Full Text] [Related]
32. [Comparative study of 2 commercial tests for the detection of HIV-1 antigens in blood and cerebrospinal fluid using immunoenzymology]. Bonnici JF; Teyssou R; Morvan J; Carteron B; Fleury HJ; du Pasquier P Ann Biol Clin (Paris); 1988; 46(9):725-9. PubMed ID: 3066238 [TBL] [Abstract][Full Text] [Related]
33. Comparison of commercial kits for the detection of antibody to human immunodeficiency virus type 1 (HIV-1) in Nigeria. Chikwem JO; Mohammed I; Ola TO East Afr Med J; 1990 Mar; 67(3):209-13. PubMed ID: 2191859 [TBL] [Abstract][Full Text] [Related]
34. Predicting human immunodeficiency virus type 1-positive sera by using two enzyme immunoassay kits in a parallel testing format. Fonseca K; Anand CM J Clin Microbiol; 1991 Nov; 29(11):2507-12. PubMed ID: 1774256 [TBL] [Abstract][Full Text] [Related]
35. Algorithms for detecting antibodies to HIV-1: results from a rural Ugandan cohort. Nunn AJ; Biryahwaho B; Downing RG; van der Groen G; Ojwiya A; Mulder DW AIDS; 1993 Aug; 7(8):1057-61. PubMed ID: 8397940 [TBL] [Abstract][Full Text] [Related]
36. A new second-generation anti-HIV-1 enzyme immunoassay using recombinant envelope and core proteins. Bäcker U; Gathof A; Howe J; Strobel E; Deinhardt F; Gürtler L; Grob P; Joller-Jemelka H; Kühnl P; Seidl S AIDS; 1988 Dec; 2(6):477-80. PubMed ID: 3149495 [TBL] [Abstract][Full Text] [Related]
37. [Evaluation of a new screening assay kit for the combined detection of HIV p24 antigen and antibody--comparison of the performance of the new kit and HIV antibody assay kits]. Hayashi T; Watanabe S; Kondo M; Saito T; Imai M Kansenshogaku Zasshi; 1999 Jul; 73(7):681-8. PubMed ID: 10481404 [TBL] [Abstract][Full Text] [Related]
38. Use of the Abbott Architect HIV antigen/antibody assay in a low incidence population. Dubravac T; Gahan TF; Pentella MA J Clin Virol; 2013 Dec; 58 Suppl 1():e76-8. PubMed ID: 24342481 [TBL] [Abstract][Full Text] [Related]
39. Characterization of serum antibody responses to recombinant HIV-1 gp160 vaccine by enzyme immunoassay. NIAID AIDS Vaccine Clinical Trials Network. Viscidi R; Ellerbeck E; Garrison L; Midthun K; Clements ML; Clayman B; Fernie B; Smith G AIDS Res Hum Retroviruses; 1990 Nov; 6(11):1251-6. PubMed ID: 1706607 [TBL] [Abstract][Full Text] [Related]
40. Frequency of human immunodeficiency virus (HIV) infection among contemporary anti-HIV-1 and anti-HIV-1/2 supplemental test-indeterminate blood donors. The Retrovirus Epidemiology Donor Study. Busch MP; Kleinman SH; Williams AE; Smith JW; Ownby HE; Laycock ME; Lee LL; Pau CP; Schreiber GB Transfusion; 1996 Jan; 36(1):37-44. PubMed ID: 8607151 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]